Can the SMART Study Data Be Used to Assess Risk Factors for Renal Disease?
TO THE EDITOR:
In the recent analysis by the SMART (Strategies for Management of Anti-Retroviral Therapy) Study Group (1), resumption of continuous antiretroviral therapy after structured treatment interruption did not fully abrogate the increased risk for serious adverse events and death associated with initial assignment to the drug conservation group of the trial. This …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
